FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular, to an antibody or a functional fragment thereof, which specifically bind to O-acetylated GD2 ganglioside. Pharmaceutical composition comprising said antibody or a functional fragment thereof is also disclosed. Method for increasing the activity of said antibody is disclosed.
EFFECT: invention effectively treats diseases associated with O-acetylated GD2 ganglioside.
22 cl, 12 dwg, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
HUMANISED ANTIBODY (H14,18) BASED ON MOUSE ANTIBODY 14,18, CONTACTING GD2, AND ITS FUSION WITH IL-2 | 2003 |
|
RU2366664C2 |
PROTEINS BINDING SPECIFIC MEMBRANE PROSTATE ANTIGEN, AND RELATED COMPOSITIONS AND METHODS | 2012 |
|
RU2632647C2 |
EASILY EXTRACTABLE BIOSPECIFIC ANTIBODIES WITH NATURAL IMMUNOGLOBULIN FORMAT | 2014 |
|
RU2569157C2 |
ANTI c-Met RECEPTOR PROTEIN ANTIBODIES | 2011 |
|
RU2608644C2 |
MICE THAT MAKE HEAVY CHAIN ANTIBODIES | 2010 |
|
RU2603102C2 |
EASILY-ISOLATED BISPECIFIC ANTIBODIES WITH NATURAL IMMUNOGLOBULIN FORMAT | 2015 |
|
RU2647758C2 |
MODIFIED CONSTANT REGION OF ANTIBODY | 2008 |
|
RU2526512C2 |
METHOD FOR MODELLING MONOCLONAL ANTIBODY ANTAGONISTIC ACTIVITY | 2009 |
|
RU2575600C2 |
FUSED PROTEINS IL-7 | 2004 |
|
RU2369616C2 |
READILY ISOLATED BISPECIFIC ANTIBODIES WITH NATIVE IMMUNOGLOBULIN FORMAT | 2010 |
|
RU2522002C2 |
Authors
Dates
2019-02-12—Published
2014-11-11—Filed